NASDAQ:ARYA ARYA Sciences Acquisition Corp III (ARYA) Stock Price, News & Analysis → Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad) Free ARYA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$10.77▼$11.2550-Day Range$9.91▼$11.1652-Week Range$9.82▼$25.89Volume366,228 shsAverage Volume320,123 shsMarket Capitalization$186.48 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get ARYA Sciences Acquisition Corp III alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About ARYA Sciences Acquisition Corp IIIARYA Sciences Acquisition Corp III does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.Read More Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. ARYA Stock News HeadlinesMarch 16, 2024 | msn.comArya Resources Ltd. (RBZ) Drills 3.5 Kilogram per Tonne (Kg. /t) Copper, 6.1 Kg. /t Nickel, and 0.247 Kg. /t Cobalt Over 36.5 MetersFebruary 10, 2024 | msn.comARYA Sciences Acquisition IV Announces New Financial ObligationApril 18, 2024 | DTI (Ad)Don’t expose yourself to stocks during the weekThe S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.February 10, 2024 | markets.businessinsider.comARYA Sciences Secures Convertible Sponsor LoanFebruary 3, 2024 | msn.comARYA Sciences Acquisition IV Extends Business Combination PeriodJuly 3, 2023 | finance.yahoo.comARYA Sciences Acquisition Corp V will redeem its Class A Ordinary Shares and will not consummate an initial business combinationJuly 3, 2023 | marketwatch.comArya Sciences Acquisition to Redeem SharesSeptember 12, 2022 | finance.yahoo.comATEX Mobilizes Drill Contractor for Phase III Program and Makes Third Option Payment on ValerianoApril 18, 2024 | DTI (Ad)Don’t expose yourself to stocks during the weekThe S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.September 7, 2022 | apnews.comArisGlobal Accelerates Growth, Announces Executive EvolutionAugust 1, 2022 | seekingalpha.comON Semiconductor Corporation (ON) CEO Hassane El-Khoury on Q2 2022 Results - Earnings Call TranscriptJune 8, 2022 | nz.finance.yahoo.comAkili Announces Veteran Life Sciences Executive Matt Franklin in Newly Created Role of President and Chief Operating OfficerJune 2, 2022 | msn.comArya.ag acquires autonomous AI agritech player PrakshepFebruary 24, 2022 | msn.comThe Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine CompanyNovember 7, 2021 | thestreet.comTradeStation Group Strikes SPAC Deal with Quantum FinTech (QFTA)October 1, 2021 | law360.comDon't Miss It: Latham, Cravath Guide Week's Hot DealsAugust 24, 2021 | nasdaq.comJefferies Top Analysts Press the ‘Buy’ Button on These 3 StocksJuly 24, 2021 | thestreet.comCCIV Adjourns Lucid Shareholder Meeting, Urges Retail ParticipationSee More Headlines Receive ARYA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ARYA Sciences Acquisition Corp III and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry Holding & Other Investment Offices Sub-IndustryN/A Current SymbolNASDAQ:ARYA CUSIPN/A CIKN/A Webwww.perceptivelife.com Phone212-284-2300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio0.52 Quick Ratio0.52 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.30 per share Price / Book37.20Miscellaneous Outstanding Shares16,710,000Free FloatN/AMarket Cap$186.48 million OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Adam Leo Stone (Age 42)CEO & Director Mr. Michael Seth Altman C.F.A. (Age 39)CFA, CFO & Director Mr. Konstantin Poukalov (Age 37)Chief Bus. Officer ARYA Stock Analysis - Frequently Asked Questions What other stocks do shareholders of ARYA Sciences Acquisition Corp III own? Based on aggregate information from My MarketBeat watchlists, some companies that other ARYA Sciences Acquisition Corp III investors own include Trevena (TRVN), Advanced Micro Devices (AMD), BioXcel Therapeutics (BTAI), ChromaDex (CDXC), Chimerix (CMRX), CTI BioPharma (CTIC), DRDGOLD (DRD) and When did ARYA Sciences Acquisition Corp III IPO? ARYA Sciences Acquisition Corp III (ARYA) raised $125 million in an initial public offering (IPO) on Friday, August 7th 2020. The company issued 12,500,000 shares at a price of $10.00 per share. Jefferies and Goldman Sachs acted as the underwriters for the IPO. This page (NASDAQ:ARYA) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIThe “Perfect Storm” for GoldGold Safe ExchangeBiden replacement revealed?Paradigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARYA Sciences Acquisition Corp III Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.